Followers | 8 |
Posts | 2087 |
Boards Moderated | 0 |
Alias Born | 07/31/2006 |
Wednesday, June 18, 2014 11:12:35 AM
Progress: NNVC -vs- SA in NY Supreme court.
Through my attorney I'm closely following the NY Supreme Court proceedings in which NanoViricides is suing Seeking Alpha to force disclosure of the identifying information for "Pump Terminator", the anonymous (for now) author of the libelous article published in January. The intent is to learn the identity of the individual responsible for publishing the libelous article and sue him or her directly for significant damages, both financial and reputational.
The parties met twice before in court earlier in the spring resulting in agreements for postponements, news of which being immediately entered in the official court records. The full hearing was finally held two weeks ago on June 2nd, and no outcomes or decisions have been officially entered in the record. I'm told this is either because the judge is considering the merits and is yet to rule, or the parties have agreed to settle among themselves and have yet to finalize the language and have it accepted by the court. Either way, a resolution of the action to force disclosure of the identity of Pump Terminator is soon to come.
My attorney believes it is very likely that SA will be compelled to disclose the identity. He states that while people have a right to free speech in such situations, they do not necessarily have a right to anonymity in the exercise of that free speech. This is especially true when elements of the speech can easily be shown to be false, and clear harm to the aggrieved party has been demonstrated.
Assuming the identity is disclosed, future litigation will focus on the issue of libel directed at the individual author, with NanoViricides attempting to prove that the author knowingly published false information, perhaps with the intent of reaping financial gain. Large monetary compensation will likely be sought by NanoViricides.
Best to all.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM